Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

News

News from the Centre for Immuno-oncology at the Nuffiled Department of Medicine, University of Oxford

Dr. Pedroza-Pacheco presenting at the Oxford Immunology Symposium last year (2024)

Oxford Immunology Symposium 2025

The BSI Oxford Immunology Group, in collaboration with the University of Oxford Immunology Network, is pleased to present a one-day showcase of the fantastic immunology research happening across Oxford.

Agonists and Antagonists in Combined Immunotherapies for Cancer

Prof. Nacho Melero delivers a talk on Immunotherapies in Cancer for GLOBAL IMMUNOTALKS

Reversing resistance to cancer immune therapy with antibodies

A new study led by Professor Ignacio Melero of NDM's Centre for Immuno-oncology and the University of Navarra and has highlighted a way to combat resistance to cancer immunotherapy in solid tumours by using antibodies that target GDF-15 protein.

Dr. Lennard Lee

Dr Lennard Lee featured in Fujifilm anniversary documentary series

CIO Dr Lennard Lee has been featured in Fujifilm Europe’s 90th Anniversary celebration documentary series, which honours 20 exceptional innovators helping to shape the future across Europe. Dr Lee has been recognised as a UK exemplar for his groundbreaking contributions to the cancer vaccines research field demonstrating a faster, simpler, and more efficient model for clinical trials.

£1.7 million for vaccine to prevent lung cancer

Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.

hood

News from Oxford Cancer